Advances in Diagnosis and Management of Cystic Fibrosis
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 4430
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cystic fibrosis (CF) is a common genetic disease caused by the defective production of CFTR protein. Understanding the basic genetic defect of CF enabled new treatment modalities including CFTR modulators in the developed countries. In the developing world, CF remains a problematic situation especially with regard to the diagnosis of the disease. Limited access to sweat testing in many parts of the world creates an inequity in the management of the disease worldwide. Genetics, which is the main part of the diagnosis, is evolving with many variants with unknown significance. In addition to this, management of CF in the centres, transition to adulthood care are other issues waiting to be resolved in many countries. The primary aims of this issue, Advances in Diagnosis and Management of Cystic Fibrosis; are to define the diagnostic difficulties, discover new diagnostic opportunities in CF, discuss the evolving genetic methods and the problems in the management of CF, as well as the transition to adulthood programs. Also, to review the recent situation in the therapeutic regimens including CFTR modulators are under the scope of this issue.
Prof. Dr. Bülent Taner Karadaǧ
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cystic fibrosis
- diagnosis
- management
- sweat testing
- genetics
- CFTR modulators
- transition
- treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
